HomeInsightsPE

Aarti Pharmalabs Ltd PE Ratio

Aarti Pharmalabs Ltd PE Ratio

stocks purchased

₹ 2.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

33.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 25, 2024

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

PE

26

Last updated on: Nov 25, 2024

Key Highlights

  • The P/E Ratio of Aarti Pharmalabs Ltd is 26 as of 25 Nov 9.00 AM .
  • The P/E Ratio of Aarti Pharmalabs Ltd changed from 12.9 on March 2023 to 18.2 on March 2024 . This represents a CAGR of 18.78% over 2 years.
  • The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 655.65 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Aarti Pharmalabs Ltd

No data available

Company Fundamentals for Aarti Pharmalabs Ltd

No data available

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

Share Price

₹ 655.65

37.85 (6.13%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Aarti Pharmalabs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024655.65
21 Nov 2024617.8
19 Nov 2024634.55
18 Nov 2024640.5
14 Nov 2024656.35
13 Nov 2024648.15
12 Nov 2024654.2
11 Nov 2024634.2
08 Nov 2024659.25
07 Nov 2024687.85

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aarti Pharmalabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarti Pharmalabs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Aarti Pharmalabs Ltd265,941
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Aarti Pharmalabs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Revenue of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Aarti Pharmalabs Ltd

No data available

* All values are in %

About Aarti Pharmalabs Ltd

  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019.
  • The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
  • It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021.

Aarti Pharmalabs Ltd News Hub

News

Aarti Pharmalabs consolidated net profit rises 17.75% in the June 2024 quarter

Net profit of Aarti Pharmalabs rose 17.75% to Rs 55.45 crore in the quarter ended June 202...

Read more

2024-08-05 00:00:00

News

Aarti Pharmalabs to discuss results

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 Octobe...

Read more

2024-10-22 00:00:00

News

Aarti Pharmalabs consolidated net profit rises 5.44% in the September 2024 quarter

Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September...

Read more

2024-10-28 00:00:00

News

Aarti Pharmalabs Company Secretary resigns

Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the ...

Read more

2024-10-28 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aarti Pharmalabs Ltd

What is the current PE Ratio of Aarti Pharmalabs Ltd?

The Current PE Ratio of Aarti Pharmalabs Ltd is 26.05 as on 25 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 25 Nov 2024.

What was the PE Ratio of Aarti Pharmalabs Ltd last year?

The PE Ratio of Aarti Pharmalabs Ltd was 12.86 last year, now the PE ratio is 26.05, showing a year-on-year growth of 102.6%.

What does the PE Ratio of Aarti Pharmalabs Ltd indicate about its stock?

The PE Ratio of Aarti Pharmalabs Ltd is 26.05. This ratio indicates that investors are willing to pay 26.05 times the earnings per share for each share of Aarti Pharmalabs Ltd.

What is the PE Ratio Growth of Aarti Pharmalabs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aarti Pharmalabs Ltd grew by 102.6% whereas, the EPS ratio grew by -1.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*